Free Trial
NASDAQ:ISPC

iSpecimen Q2 2025 Earnings Report

iSpecimen logo
$0.67 -0.04 (-5.22%)
Closing price 04:00 PM Eastern
Extended Trading
$0.68 +0.01 (+0.80%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iSpecimen EPS Results

Actual EPS
-$0.42
Consensus EPS
-$3.80
Beat/Miss
Beat by +$3.38
One Year Ago EPS
N/A

iSpecimen Revenue Results

Actual Revenue
$0.71 million
Expected Revenue
$3.10 million
Beat/Miss
Missed by -$2.39 million
YoY Revenue Growth
N/A

iSpecimen Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
7:00AM ET

Earnings Documents

iSpecimen Earnings Headlines

An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
See More iSpecimen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like iSpecimen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iSpecimen and other key companies, straight to your email.

About iSpecimen

iSpecimen (NASDAQ:ISPC) provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

View iSpecimen Profile

More Earnings Resources from MarketBeat